Search research articles
Contact Us
Filters
Showing results (521-530 of 554) with videos related to
Page
of 56
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 2014
Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study
Matthew R Smith, Christopher J Sweeney, Paul G Corn, et al.
Lancet (London, England)
|
March 13, 2016
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
Naomi B Haas, Judith Manola, Robert G Uzzo, et al.
JAMA Health Forum
|
October 31, 2025
Manifestations of Structural Racism and Inequities in Cardiovascular Health Across US Neighborhoods
Wayne R Lawrence, Hyokyoung G Hong, Faustine Williams, et al.
JNCI Cancer Spectrum
|
April 25, 2020
Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors
Sarina A Piha-Paul, Christine L Hann, Christopher A French, et al.
Research Integrity and Peer Review
|
December 9, 2020
Comparing quality of reporting between preprints and peer-reviewed articles in the biomedical literature
Clarissa F D Carneiro, Victor G S Queiroz, Thiago C Moulin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2021
From Basic Science to Clinical Translation in Kidney Cancer: A Report from the Second Kidney Cancer Research Summit
Toni K Choueiri, Laurence Albiges, Michael B Atkins, et al.
Infection
|
September 17, 2013
Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)
J Thoden, A Potthoff, J R Bogner, et al.
Cancer Discovery
|
February 24, 2025
Presence of Tertiary Lymphoid Structures and Exhausted Tissue-Resident T Cells Determines Clinical Response to PD-1 Blockade in Renal Cell Carcinoma
Miya B Hugaboom, Lena V Wirth, Kelly Street, et al.
Future Oncology (London, England)
|
April 11, 2019
The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?
Hiten D Patel, Maneka Puligandla, Brian M Shuch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2026
Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti-PD-1 Therapy in Clear Cell Renal Cell Carcinoma: analyses of the HCRN GU16-260 trial
Nourhan El Ahmar, Morgan A Paul, Berkay Simsek, et al.
Page
of 56
Search research articles
Search
Showing results (521-530 of 554) with videos related to
Sort By:
Page
of 56
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 2014
Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study
Matthew R Smith, Christopher J Sweeney, Paul G Corn, et al.
Lancet (London, England)
|
March 13, 2016
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
Naomi B Haas, Judith Manola, Robert G Uzzo, et al.
JAMA Health Forum
|
October 31, 2025
Manifestations of Structural Racism and Inequities in Cardiovascular Health Across US Neighborhoods
Wayne R Lawrence, Hyokyoung G Hong, Faustine Williams, et al.
JNCI Cancer Spectrum
|
April 25, 2020
Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors
Sarina A Piha-Paul, Christine L Hann, Christopher A French, et al.
Research Integrity and Peer Review
|
December 9, 2020
Comparing quality of reporting between preprints and peer-reviewed articles in the biomedical literature
Clarissa F D Carneiro, Victor G S Queiroz, Thiago C Moulin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2021
From Basic Science to Clinical Translation in Kidney Cancer: A Report from the Second Kidney Cancer Research Summit
Toni K Choueiri, Laurence Albiges, Michael B Atkins, et al.
Infection
|
September 17, 2013
Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)
J Thoden, A Potthoff, J R Bogner, et al.
Cancer Discovery
|
February 24, 2025
Presence of Tertiary Lymphoid Structures and Exhausted Tissue-Resident T Cells Determines Clinical Response to PD-1 Blockade in Renal Cell Carcinoma
Miya B Hugaboom, Lena V Wirth, Kelly Street, et al.
Future Oncology (London, England)
|
April 11, 2019
The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?
Hiten D Patel, Maneka Puligandla, Brian M Shuch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2026
Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti-PD-1 Therapy in Clear Cell Renal Cell Carcinoma: analyses of the HCRN GU16-260 trial
Nourhan El Ahmar, Morgan A Paul, Berkay Simsek, et al.
Page
of 56